Remimazolam
- Generic Name
- Remimazolam
- Brand Names
- Byfavo
- Drug Type
- Small Molecule
- Chemical Formula
- C21H19BrN4O2
- CAS Number
- 308242-62-8
- Unique Ingredient Identifier
- 7V4A8U16MB
- Background
Remimazolam is an ultra short-acting benzodiazepine used in the induction and maintenance of sedation during short (<30 minute) procedures. Recent trends in anesthesia-related drug development have touted the benefits of so-called "soft drugs" - these agents, such as remifentanil, are designed to be metabolically fragile and thus susceptible to rapid biotran...
- Indication
Remimazolam is indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.
- Associated Conditions
- Procedural Sedation
- Associated Therapies
- -
Remimazolam Besylate in Sedation of Postcardioperative Patients
- Conditions
- Interventions
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- First Affiliated Hospital of Zhejiang University
- Target Recruit Count
- 120
- Registration Number
- NCT06716840
Comparison of General Anesthesia Hemodynamics Between R and P in Patients Undergoing Laparoscopic Hepatectomy
- First Posted Date
- 2024-12-03
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Sun Yat-sen University
- Target Recruit Count
- 88
- Registration Number
- NCT06714669
- Locations
- 🇨🇳
Sun Yat-san University Cancer Center, Guangzhou, Guangdong, China
RCT Comparing Remimazolam With Propofol Under EEG DSA Guidance During Cardiac Electrophysiology Studies and Ablation
- First Posted Date
- 2024-11-22
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Taipei Veterans General Hospital, Taiwan
- Target Recruit Count
- 200
- Registration Number
- NCT06700681
- Locations
- 🇨🇳
Taipei Veterans General Hospital, Taipei, Taiwan
Clinical Studies of the Efficacy and Safety of Remimazolam for Anesthesia Induction and Maintenance in Elderly Patients
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Affiliated Hospital of Nantong University
- Target Recruit Count
- 60
- Registration Number
- NCT06690424
Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment
- Conditions
- Interventions
- First Posted Date
- 2024-10-29
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Yeongseok Yun
- Target Recruit Count
- 30
- Registration Number
- NCT06664138
- Locations
- 🇰🇷
Dankook University Hospital, Cheon-an, Korea, Republic of
Remimazolam Versus Midazolam for Sedation During Upper GI Endoscopy: a Randomized Controlled Trial
- Conditions
- Interventions
- First Posted Date
- 2024-09-26
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Koen Munters
- Target Recruit Count
- 148
- Registration Number
- NCT06614036
- Locations
- 🇳🇱
Gelre Hospitals, Apeldoorn, Gelderland, Netherlands
🇳🇱Rijnstate hospital, Arnhem, Gelderland, Netherlands
🇳🇱St Antonius hospital, Nieuwegein, Utrecht, Netherlands
Effect of Remazolam on Hemodynamics During Hepatectomy
- Conditions
- Interventions
- First Posted Date
- 2024-08-22
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Jun Zhang
- Target Recruit Count
- 70
- Registration Number
- NCT06565715
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
Comparison of Efficacy and Safety Between Ciprofol and Remimazolam During Fiberoptic Bronchoscopy
- Conditions
- Interventions
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Anhui Provincial Hospital
- Target Recruit Count
- 190
- Registration Number
- NCT06531915
Comparison of Remimazolam and Propofol on Emergence in Elderly Orthopedic Patients Under General Anesthesia
- First Posted Date
- 2024-07-22
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- Central South University
- Target Recruit Count
- 136
- Registration Number
- NCT06513923
- Locations
- 🇨🇳
Department of Anesthesiology, The Second Xiangya Hospital, Changsha, Hunan, China
🇨🇳The Second Xiangya Hospital, Changsha, Hunan, China
Comparison of Remimazolam and Propofol for Recovery of Ambulatory Upper Airway Surgery
- Conditions
- Interventions
- First Posted Date
- 2024-07-18
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- Chung-Ang University Gwangmyeong Hospital
- Target Recruit Count
- 116
- Registration Number
- NCT06507202
- Locations
- 🇰🇷
ChungAng University Gwangmyeong Hospital, Gyeonggi-do, Gwangmyeon-si, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.